Basic science for the clinician 27: Toll-like receptors and nudeotide oligomerization domains

Journal of Clinical Rheumatology

Volumn 11, Issue 3, 2005, Pages 176-179

  Sigal, Leonard H ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Nucleotide oligomerization domains (NOD); Pathogen associated molecular pattern (PAMP); Toll like receptors (TLR)

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; TOLL LIKE RECEPTOR;

ATHEROSCLEROSIS; CHLAMYDIA; DEFENSE MECHANISM; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE OLIGOMERIZATION DOMAIN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REACTIVE ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; YERSINIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; INTERLEUKIN-18; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTORS;

EID: 20844449910     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000165290.47682.57     Document Type: Review

References (2)

1. Leadbetter EA, Rifkin R, Marshak-Rothstein A. Toll-like receptors and activation of autoreactive B cells. In: Nemazee B, ed. B Cell Biology in Autoimmunity. Current Directions in Autoimmunity. Basel: Karger; 2003:105-122.
2. Michelson KS, Doherty TM, Shah PK, et al. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol. 2004;173: 5901-5907.